Additionally, a previous study reported a statistically significant difference in CEA levels based on lymph node metastasis, N grade, and T stage, with patients in the late-stage pancreatic cancer (PC) group exhibiting significantly higher values compared to those in the early-stage PC group21. The gene discussed is CEACAM5; the disease is pancreatic neoplasm.